Casandra
Casandra Test Code QD20982Version 1 (DRAFT)
Performing Lab
Alpha-Fetoprotein (AFP) and AFP‑L3
Clinical Use
Order TestUse
This assay is intended for use in the assessment of risk for the development of hepatocellular carcinoma (HCC) in patients with chronic liver disease.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
AFP‑L3
ProteinAFP‑L3 • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Alpha‑Fetoprotein
ProteinAFP • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
Not provided
Minimum Volume
0.5 mL
Container
Serum separator tube or plain red tube; centrifuge and aliquot 1.5 mL serum
Collection Instructions
Centrifuge SST; if plain red, centrifuge and aliquot serum
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Ambient: 72 hours |
| Refrigerated | 5 days |
| Frozen | 2 years |